One or more of the required application components couldn’t be loaded. Please, refresh the page.

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jan 10 04:00PM ET
15.90
Dollar change
-0.11
Percentage change
-0.69%
INMD - Stock Price Chart
IndexRUT P/E8.59 EPS (ttm)1.85 Insider Own11.56% Shs Outstand84.62M Perf Week-6.25%
Market Cap1.35B Forward P/E7.92 EPS next Y2.01 Insider Trans0.00% Shs Float74.84M Perf Month-15.61%
Income153.67M PEG- EPS next Q0.53 Inst Own53.63% Short Float7.91% Perf Quarter5.65%
Sales423.75M P/S3.18 EPS this Y-27.10% Inst Trans-12.31% Short Ratio5.89 Perf Half Y-5.47%
Book/sh8.71 P/B1.83 EPS next Y7.10% ROA19.00% Short Interest5.92M Perf Year-27.99%
Cash/sh8.09 P/C1.96 EPS next 5Y- ROE21.04% 52W Range14.87 - 26.80 Perf YTD-4.79%
Dividend Est.- P/FCF8.54 EPS past 5Y47.29% ROI20.70% 52W High-40.67% Beta2.14
Dividend TTM- Quick Ratio9.91 Sales past 5Y35.17% Gross Margin81.64% 52W Low6.93% ATR (14)0.65
Dividend Ex-Date- Current Ratio10.68 EPS Y/Y TTM-13.09% Oper. Margin32.07% RSI (14)31.92 Volatility3.47% 3.20%
Employees581 Debt/Eq0.01 Sales Y/Y TTM-15.05% Profit Margin36.26% Recom2.43 Target Price20.83
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q1.84% Payout0.00% Rel Volume1.23 Prev Close16.01
Sales Surprise2.94% EPS Surprise23.54% Sales Q/Q2.72% EarningsFeb 06 BMO Avg Volume1.01M Price15.90
SMA20-7.74% SMA50-12.04% SMA200-10.10% Trades Volume1,237,013 Change-0.69%
Date Action Analyst Rating Change Price Target Change
Oct-17-24Initiated BTIG Research Buy $25
Jul-23-24Downgrade Jefferies Buy → Hold $21 → $19
Nov-03-23Downgrade UBS Buy → Neutral $52 → $24
Oct-13-23Downgrade Canaccord Genuity Buy → Hold $55 → $22
Mar-29-23Initiated UBS Buy $40
Feb-17-23Downgrade Needham Buy → Hold
Dec-21-22Initiated Barclays Overweight $44
Oct-12-22Initiated Jefferies Buy $40
May-25-21Initiated Barclays Overweight $92
May-18-21Initiated Needham Buy $94
Jan-08-25 07:00AM
07:00AM
Dec-10-24 10:53PM
Nov-06-24 08:30AM
Oct-31-24 07:29AM
03:07AM Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.Finviz Elite
03:07AM
01:25AM
Oct-30-24 03:45PM
08:10AM
07:07AM
07:00AM
Oct-29-24 09:11AM
Oct-24-24 07:03AM
Oct-23-24 10:01AM
Oct-14-24 09:40AM
05:25PM Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.Finviz Elite
Oct-13-24 05:25PM
Oct-10-24 07:00AM
Oct-09-24 03:42PM
Oct-02-24 07:28AM
Oct-01-24 07:00AM
Sep-26-24 09:40AM
Sep-23-24 05:34AM
Sep-10-24 09:40AM
07:00AM
Sep-04-24 08:30AM
Sep-01-24 11:27PM
Aug-14-24 11:05AM
Aug-09-24 06:46AM
Aug-06-24 08:30AM
Aug-01-24 10:30PM
08:15AM Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.Finviz Elite
08:15AM
07:14AM
07:00AM
Jul-31-24 08:03AM
Jul-25-24 10:02AM
08:15AM
Jul-17-24 08:03AM
Jul-11-24 08:30AM
Jul-01-24 06:00AM
May-16-24 08:00AM
May-08-24 08:03AM
May-03-24 12:12PM
11:41AM
May-02-24 07:15PM
01:31PM
11:55AM
09:30AM
08:30AM
07:00AM
Apr-25-24 10:01AM
Apr-15-24 07:00AM
05:45AM
Apr-10-24 05:45AM
Apr-09-24 07:00AM
Apr-03-24 06:00PM
08:00AM
Apr-01-24 09:30AM
09:00AM
05:45AM
Mar-28-24 06:00PM
Mar-26-24 08:02AM
Mar-21-24 06:00PM
Mar-19-24 09:00AM
Mar-15-24 05:50PM
09:30AM
Mar-13-24 11:45AM
06:09AM
Mar-12-24 07:24AM
05:45AM
Mar-04-24 08:30AM
Feb-28-24 09:47AM
Feb-23-24 01:00PM
09:30AM
Feb-22-24 07:12PM
Feb-14-24 09:36AM
02:29AM
Feb-13-24 06:15PM
02:06PM
08:02AM
07:21AM
07:00AM
Feb-12-24 05:37AM
Feb-05-24 05:50PM
Jan-30-24 05:50PM
Jan-27-24 06:57PM
Jan-24-24 05:50PM
Jan-23-24 06:00PM
Jan-17-24 06:00PM
Jan-16-24 07:00AM
Jan-08-24 05:50PM
Jan-07-24 08:30AM
Jan-04-24 06:00PM
Dec-29-23 09:30AM
Dec-28-23 06:00PM
Dec-22-23 05:50PM
Dec-15-23 09:00AM
Dec-13-23 07:33AM
Dec-08-23 10:13AM
Dec-06-23 07:00AM
05:40AM
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Institutional Ownership

NORDEA INVESTMENT MANAGEMENT AB0.35%
Income Statement Balance Sheet Cash Flow

Data

Timeframe

Period End DateTTM12/31/202312/31/202212/31/202112/31/202012/31/201912/31/201812/31/2017
Period Length12 Months12 Months12 Months

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, historical statements, and much more.

Learn more
Total Revenue
423.75492.05454.27
Cost of Goods Sold Incl. D&A
77.8080.7173.49
Gross Profit
345.95411.34380.79
Selling, General and Administrative Excl. Other
210.04215.68182.93
Research and Development
13.9413.4112.43
Other Operating Expense
0.000.000.00
Operating Income
135.91195.66197.85
Interest Expense
Unusual Expense
0.000.000.00
Net Income Before Taxes
171.42217.27201.47
Income Taxes
17.7519.3539.95
Consolidated Net Income
153.67197.92161.52
Net Income From Continuing Operations
153.67197.92161.52
Net Income
153.67197.92161.52
EPS (Recurring)
1.972.301.89
EPS (Basic, Before Extraordinaries)
1.882.371.96
EPS (Diluted)
1.852.301.89
EBITDA
136.51196.28198.53
Price To Earnings Ratio
8.598.5910.26
Price To Sales Ratio
3.293.886.71
Gross Margin
81.6483.6083.82
Operating Margin
32.0739.7643.55
Net Margin
36.2640.2235.56
Shares Outstanding
84.6283.9882.54
Market Capitalization
1,345.441,345.441,851.07